These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 10602731)

  • 1. Characterization of the antiviral effect of 2',3'-dideoxy-2', 3'-didehydro-beta-L-5-fluorocytidine in the duck hepatitis B virus infection model.
    Le Guerhier F; Pichoud C; Guerret S; Chevallier M; Jamard C; Hantz O; Li XY; Chen SH; King I; Trépo C; Cheng YC; Zoulim F
    Antimicrob Agents Chemother; 2000 Jan; 44(1):111-22. PubMed ID: 10602731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal models for the study of HBV infection and the evaluation of new anti-HBV strategies.
    Zoulim F; Berthillon P; Guerhier FL; Seigneres B; Germon S; Pichoud C; Cheng YC; Trepo C
    J Gastroenterol Hepatol; 2002 Dec; 17 Suppl():S460-3. PubMed ID: 12534778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo.
    Zoulim F; Dannaoui E; Borel C; Hantz O; Lin TS; Liu SH; Trépo C; Cheng YC
    Antimicrob Agents Chemother; 1996 Feb; 40(2):448-53. PubMed ID: 8834896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus.
    Le Guerhier F; Pichoud C; Jamard C; Guerret S; Chevallier M; Peyrol S; Hantz O; King I; Trépo C; Cheng YC; Zoulim F
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1065-77. PubMed ID: 11257017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pyrimidine and purine analog combinations in the duck hepatitis B virus infection model.
    Seignères B; Martin P; Werle B; Schorr O; Jamard C; Rimsky L; Trépo C; Zoulim F
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1842-52. PubMed ID: 12760857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of 2',3'-dideoxy-2',3'-didehydro-beta-L(-)-5-fluorocytidine and its activity in combination with clinically approved anti-human immunodeficiency virus beta-D(+) nucleoside analogs in vitro.
    Dutschman GE; Bridges EG; Liu SH; Gullen E; Guo X; Kukhanova M; Cheng YC
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1799-804. PubMed ID: 9661024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of L-Fd4C and related nucleoside analogs as promising antiviral agents.
    Chen SH
    Curr Med Chem; 2002 May; 9(9):899-912. PubMed ID: 11966452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of 2'-fluoro-5-methyl-beta-L-arabinofuranosyl-uracil on duck hepatitis B virus replication.
    Aguesse-Germon S; Liu SH; Chevallier M; Pichoud C; Jamard C; Borel C; Chu CK; Trépo C; Cheng YC; Zoulim F
    Antimicrob Agents Chemother; 1998 Feb; 42(2):369-76. PubMed ID: 9527788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nucleoside analogue therapy on duck hepatitis B viral replication in hepatocytes and bile duct epithelial cells in vivo.
    Nicoll A; Locarnini S; Chou ST; Smallwood R; Angus P
    J Gastroenterol Hepatol; 2000 Mar; 15(3):304-10. PubMed ID: 10764033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks.
    Fourel I; Cullen JM; Saputelli J; Aldrich CE; Schaffer P; Averett DR; Pugh J; Mason WS
    J Virol; 1994 Dec; 68(12):8321-30. PubMed ID: 7966625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-hepatitis B virus activity and metabolism of 2',3'-dideoxy-2',3'-didehydro-beta-L(-)-5-fluorocytidine.
    Zhu YL; Dutschman DE; Liu SH; Bridges EG; Cheng YC
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1805-10. PubMed ID: 9661025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of inhibition of duck hepatitis B virus polymerase by (-)-beta-L-2',3'-dideoxy-3'-thiacytidine.
    Severini A; Liu XY; Wilson JS; Tyrrell DL
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1430-5. PubMed ID: 7492080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro.
    Delmas J; Schorr O; Jamard C; Gibbs C; Trépo C; Hantz O; Zoulim F
    Antimicrob Agents Chemother; 2002 Feb; 46(2):425-33. PubMed ID: 11796353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory activity of dioxolane purine analogs on wild-type and lamivudine-resistant mutants of hepadnaviruses.
    Seignères B; Pichoud C; Martin P; Furman P; Trépo C; Zoulim F
    Hepatology; 2002 Sep; 36(3):710-22. PubMed ID: 12198665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease of wild-type and precore mutant duck hepatitis B virus replication during lamivudine treatment in white Pekin ducks infected with the viruses.
    Tomita T; Yokosuka O; Tagawa M; Saisho H; Tamura S; Fukuda I; Omata M
    J Hepatol; 2000 May; 32(5):850-8. PubMed ID: 10845674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral effects of PNA in duck hepatitis B virus infection model.
    Chen ZY; Cheng AC; Wang MS; Xu DW; Zeng W; Li Z
    Acta Pharmacol Sin; 2007 Oct; 28(10):1652-8. PubMed ID: 17883953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The carbocyclic analog of 2'-deoxyguanosine induces a prolonged inhibition of duck hepatitis B virus DNA synthesis in primary hepatocyte cultures and in the liver.
    Fourel I; Saputelli J; Schaffer P; Mason WS
    J Virol; 1994 Feb; 68(2):1059-65. PubMed ID: 8289335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral activity of 2',3'-dideoxy-beta-L-5-fluorocytidine (beta-L-FddC) and 2',3'-dideoxy-beta-L-cytidine (beta-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro.
    Lin TS; Luo MZ; Liu MC; Pai SB; Dutschman GE; Cheng YC
    Biochem Pharmacol; 1994 Jan; 47(2):171-4. PubMed ID: 8304960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Establishment of an in vivo model for duck hepatitis B virus infection using Hubei duckling].
    Hu Q; Fang Y; Zhang ZM; Zhang XY; Zhang ZH; Yang DL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):113-5. PubMed ID: 18574531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of 2',3'-dideoxy-L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV).
    Lin TS; Luo MZ; Liu MC; Pai SB; Dutschman GE; Cheng YC
    J Med Chem; 1994 Mar; 37(6):798-803. PubMed ID: 8145230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.